Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hemophilia A or B”

95 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 95 results

Not applicableStudy completedNCT01510418
What this trial is testing

Socialization of Adult Men With Congenital Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
Dana-Farber Cancer Institute 27
Large-scale testing (Phase 3)Study completedNCT01757405
What this trial is testing

Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen

Who this might be right for
Hemophilia AHemophilia B
Baxalta now part of Shire 40
Not applicableStudy completedNCT00936312
What this trial is testing

Females With Severe or Moderate Hemophilia A or B: an International Multi-center Study

Who this might be right for
Hemophilia AHemophilia B
Weill Medical College of Cornell University 200
Post-approval studies (Phase 4)Study completedNCT00638001
What this trial is testing

Impact of Conservative Treatment by Custom-made Orthoses in Patients With Haemophilic Ankle Arthropathy

Who this might be right for
Haemophilia AHaemophilia B
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 70
Not applicableEnrolling By InvitationNCT03655223
What this trial is testing

Early Check: Expanded Screening in Newborns

Who this might be right for
Spinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more
RTI International 30,000
Large-scale testing (Phase 3)Study completedNCT00851721
What this trial is testing

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor

Who this might be right for
Hemophilia A or B With InhibitorsHemophilia AHemophilia B
Baxalta now part of Shire 52
Large-scale testing (Phase 3)Ended earlyNCT02895945
What this trial is testing

BAX 802 in CHA With Inhibitors

Who this might be right for
Hemophilia A
Baxalta now part of Shire 8
Testing effectiveness (Phase 2)Study completedNCT06289166
What this trial is testing

Safety and Efficacy of STSP-0601 in Adult Patients with Hemophilia a or B with Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 25
Testing effectiveness (Phase 2)Study completedNCT02974855
What this trial is testing

PF-06741086 Multiple Dose Study in Severe Hemophilia

Who this might be right for
Hemophilia A or B
Pfizer 27
Large-scale testing (Phase 3)Study completedNCT03587116
What this trial is testing

Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

Who this might be right for
Hemophilia BHemophilia A
Pfizer 212
Early research (Phase 1)Study completedNCT01949792
What this trial is testing

A Trial Investigating the Pharmacokinetics and Pharmacodynamics of rFVIIa in Patients With Haemophilia A or B With or Without Inhibitors

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia A With Inhibitors+2 more
Novo Nordisk A/S 6
Post-approval studies (Phase 4)Study completedNCT00002386
What this trial is testing

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Who this might be right for
HIV InfectionsHemophilia A
Merck Sharp & Dohme LLC 55
Not applicableStudy completedNCT03055611
What this trial is testing

Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B

Who this might be right for
Haemophilia AHaemophilia B
Swedish Orphan Biovitrum 201
Large-scale testing (Phase 3)Study completedNCT00618098
What this trial is testing

Study of Octaplex (Human Prothrombin Complex Concentrate) and Fresh Frozen Plasma in Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery or Invasive Procedures

Who this might be right for
Reversal of Anticoagulant Treatment
Octapharma 200
Testing effectiveness (Phase 2)Study completedNCT05619926
What this trial is testing

Safety and Efficacy of STSP-0601 in Adult Patients With Hemophilia A or B Without Inhibitor

Who this might be right for
Hemophilia
Staidson (Beijing) Biopharmaceuticals Co., Ltd 32
Testing effectiveness (Phase 2)Study completedNCT04073498
What this trial is testing

The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B)

Who this might be right for
Hemophilia aHemophilia B
ApcinteX Ltd 39
Large-scale testing (Phase 3)Study completedNCT02448680
What this trial is testing

A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa

Who this might be right for
Hemophilia A With InhibitorsHemophilia B With Inhibitors
Laboratoire français de Fractionnement et de Biotechnologies 25
Not applicableUnknownNCT06158334
What this trial is testing

Study of Surgical Practices in Patients With Haemophilia A or B Treated With an Extended Half-life Recombinant Factor VIII-Fc or IX-Fc (ELOCTA®, ALPROLIX®)

Who this might be right for
Hemophilia AHemophilia B
Hospices Civils de Lyon 400
Testing effectiveness (Phase 2)Looking for participantsNCT06611436
What this trial is testing

BeCoMe-9: A Clinical Study of BE-101 for the Treatment of Adults With Moderately Severe or Severe Hemophilia B

Who this might be right for
Hemophilia BHemophilia B, Moderately Severe or Severe
Be Biopharma 24
Large-scale testing (Phase 3)Study completedNCT03417245
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 120
Load More Results